![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Watson Confirms Simcor Patent Challenge
Watson Confirms Simcor Patent Challenge
May 5, 2010
Watson Pharmaceuticals Wednesday confirmed that its subsidiary, Watson Laboratories- Florida,
filed an Abbreviated New Drug Application with the FDA seeking approval to market its 1000 mg/20 mg form of niacin extended-release/simvastatin tablets.
Benzinga
Benzinga
Upcoming Events
-
21Oct